NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Hunan Pharmaceutical Development Private Equity Fund Management

Hunan Pharmaceutical Development Private Equity Fund Management

Changshahnpdig.com

Overview

Hunan Pharmaceutical Development Private Equity Fund Management Co., Ltd. is a Chinese investment firm that manages private equity funds focused on the healthcare and pharmaceutical industries.

Portfolio Companies

1

Website

hnpdig.com

Investments

Hunan Pharmaceutical Development Private Equity Fund Management investments
CompanyDateStageLead
Prisys Biotechnology Co., Ltd.Nov 2020Series BCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersChangsha
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.